Our Unique Business Model
The Acuitas business model is unique. As the global leader in developing lipid nanoparticles (LNP) for nucleic acid therapeutics, our full focus is on refining and improving our LNP for use by our partners. Supporting partner success is at the heart
Acuitas – Who We Are and How We Got Here
As the global leader in developing lipid nanoparticles (LNP) for nucleic acid therapeutics, the Acuitas team advances human health through our work with our partners – and by continuing to refine and improve our LNP. We are growing our team and